Know How Tresiba Compares to Other Basal Insulins for Type 2 Diabetes

Tresiba (treh-SEE-bah, insulin degludec) is the newest long-acting basal insulin...after Levemir (detemir), Lantus and Basaglar (glargine 100 units/mL), and Toujeo (glargine 300 units/mL).

Tresiba lasts about 42 hours...compared to about 24 hours for Levemir, Lantus, or Basaglar...and over 24 hours for Toujeo.

But this doesn't mean that Tresiba works better than the others.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote